Release Date: 04/11/10 09:57 Summary: Suspension from Official Quotation Price Sensitive: Yes Download Document 196.13KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%